Ute Dugan Selected Research

Immunotherapy

1/2022	Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
1/2021	CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ute Dugan Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 07/2007
3	Adenocarcinoma 01/2022 - 07/2007
3	Breast Neoplasms (Breast Cancer) 01/2010 - 07/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2009 - 01/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Sepsis (Septicemia) 01/2021

Drug/Important Bio-Agent (IBA)

5	Capecitabine (Xeloda)FDA Link 01/2010 - 07/2007
3	Bevacizumab (Avastin)FDA Link 01/2009 - 07/2007
2	sotigalimabIBA 01/2022 - 01/2021
2	NivolumabIBA 01/2022 - 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2009
1	Taxoids (Taxanes)IBA 07/2007
1	AnthracyclinesIBA 07/2007
1	Estrogen ReceptorsIBA 07/2007

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Immunotherapy 01/2022 - 01/2021
1	Palliative Care (Palliative Therapy) 01/2021